DSM and TU Delft Establish AI Laboratory

DSM and TU Delft have established an artificial intelligence laboratory to drive bioscience innovation.
DSM and TU Delft have established an artificial intelligence laboratory to drive bioscience innovation.

Royal DSM, a science-based company in nutrition, health and sustainable living, and TU Delft, a biotechnology research institute, has announced the establishment of the Artificial Intelligence Lab for Biosciences (AI4B.io Lab).

Related: DSM x Valio to Develop Sustainable Dairy Products

This laboratory will be the first of its kind in Europe to apply artificial intelligence (AI) to full-scale biomanufacturing, from microbial strain development to process optimization and scheduling.

DSM will invest €2.5 million into the laboratory over the first five years. TU Delft will invest in 24 interdisciplinary AI laboratories on a broad range of topics to further drive collaboration between scientists working in AI and scientists from other domains.

The AI4B.io Lab will be part of the Dutch National Innovation Center for AI (ICAI), which works to keep the Netherlands at the forefront of knowledge and talent development in AI. It will be led by Professor Marcel Reinders, director TU Delft Bioengineering Institute.

The Lab will also collaborate with Planet B.io, the open-innovation ecosystem at the Biotech Campus Delft. 

It will be the third ICAI Lab on the TU Delft campus, joining the AI for Retail Lab Delft of Ahold Delhaize, and the AI for Fintech Lab of ING.

Professor Marcel Reinders, director TU Delft Bioengineering Institute said,‘’Biotechnology can contribute significantly to solving major societal challenges, such as climate change, healthy nutrition for the world’s rapidly growing population, and raw material scarcity. AI plays a crucial role in the development of biotechnology applications, but, scientifically speaking, there are still many unanswered questions at the cellular, lab, and process level. By linking our fundamental research to concrete opportunities at DSM, we can maximize our impact.”

Marcus Remmers, chief technology officer DSM said, “TU Delft has a proven track record of groundbreaking research in AI, bioengineering, and bioinformatics. DSM is a global, science-based company that creates sustainable, bio-based products and solutions at commercial scale. This makes our parties the perfect match to tackle important scientific and societal challenges together.”

Cindy Gerhardt, managing director Planet B.io said, ‘’At Planet B.io, we stimulate open innovation and collaboration between startups, corporations, and knowledge institutes to develop bio-based products and solutions. We look forward to working together with the AI4B.io Lab to maximize the potential of AI and biosciences.’’

More in Home